Nordic, a top-rated healthcare consulting firm, on 2 Oct 2020 announced its acquisition of Tasman Global, a healthc...
Building on the learnings from the ongoing global COVID-19 pandemic, in mid-September, Ministers of Health and Fin...
The Global Virus Network (GVN), a coalition of the world's leading medical and basic virology research centers working t...
Johnson & Johnson has announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for i...
The publication and subsequent retraction in June, 2020, of the article 'Hydroxychloroquine (HCQ) or chloroquine wi...
The COVID-19 pandemic has disrupted the traditional business models of companies. While digital transformation has been ...
GELITA AG, the global market leader in the field of gelatine and collagen peptides, appoints Dr. Sven Abend to the Execu...
US-based Fitbit has recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA), as well as...
Oxford university and AstraZeneca are to resume the international clinical trial of their proposed coronavirus vaccine c...
Cytiva, a global life sciences leader, is expanding its manufacturing capacity and hiring personnel in key areas to supp...
“The post COVID-19 world will see an influx of information and research to cope with evolving healthcare needs. Th...
Merck has announced a € 59 million expansion of its Highly potent active pharmaceutical ingredients (HPAPI) and&nbs...
The Rockefeller Foundation and ACCESS Health International on 9 Sep 2020 launched a new report on the important rol...
AstraZeneca has temporarily put on hold the Phase III study of the University of Oxford COVID-19 vaccine following an un...
INOVIO, a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect peop...
Sirtex Medical, a leading manufacturer of targeted liver cancer therapies in the U.S., Australia, Europe ...
Taiwan Ministry of Health and Welfare announced signing of its first Memorandum of Understanding on Health Cooperation w...
The U.S. Food and Drug Administration broadened the scope of the existing emergency use authorization (EUA) for the drug...
